Twist Bioscience grants CFO Adam Laponis 7,828 restricted stock units vesting over four years
TWST•Twist Bioscience granted CFO Adam Laponis 7,828 restricted stock units, vesting over four years.
1. Stock unit grant
Twist Bioscience awarded Chief Financial Officer Adam Laponis 7,828 shares of common stock on November 16, 2026.




